Evidence map›Paper›PMID 35484699›Full record

ArticleRevista de neurologia2022

Telemedicine in the monitoring of patients with dementia: a Brazilians caregivers's perspective.

B Moreira-Constantin, G Carpen-Padovani, A V Cordeiro-Gaede, A Chamma-Coelho, R K Martínez-Souza, R Nisihara

Open access · hybridAbstract read
In one paragraph

Article in Revista de neurologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

B Moreira-ConstantinUniversidade Positivo, Curitiba, Brasil.
G Carpen-PadovaniUniversidade Positivo, Curitiba, Brasil.
A V Cordeiro-GaedeUniversidade Positivo, Curitiba, Brasil.
A Chamma-CoelhoUniversidade Positivo, Curitiba, Brasil.
R K Martínez-SouzaUniversidade Positivo, Curitiba, Brasil.
R NisiharaUniversidade Positivo, Curitiba, Brasil.
Universidade Positivo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe SARS-CoV-2 (COVID-19) pandemic warranted expanded care via telemedicine across a breath of medical specialties. The aim of the study is to analyze the preferences of caregivers of patients with dementia on the use of telemedicine in monitoring these patients. SUBJECTS AND

methodsCaregivers and family members responsible for patients with dementia completed an online self-applicable questionnaire, which was distributed in Facebook and WhatsApp groups between April and October 2020.

results130 responses were obtained; most caregivers were women (83.8%), of whom 60% were daughters of patients. Most patients were also women (75.3%). Alzheimer's disease caused dementia in 73% of cases. The Internet was accessible to 98% of respondents, yet less than half (33.8%) had used telemedicine at least once. Although 66.9% of caregivers would be willing to use telemedicine if the doctor offered it, 63% believed that the cost of video consultations should be lower than those face-to-face. During the COVID-19 pandemic, 85.3% of caregivers needed to contact the physician: just over half of these consultations were face-to-face (52.2%), but telemedicine was preferred (62.3%) if possible.

conclusionCaregivers accepted and were interested in telemedicine as a tool for monitoring patients with dementia, especially those with walking difficulties.

Indexed as

COVID-19DementiaTelemedicineBrazilCaregiversFemaleHumansMalePandemicsSARS-CoV-2

Identifiers

PMID35484699
PMCPMC11502170
OpenAlexW4225130879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.